CAPTRUST Financial Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,402	Closed	-$41K	–	2992
2022 Q2	$41K	Sell	1,402 -675	-32%	-$20.1K	﹤0.01%	2907
2022 Q1	$72K	Buy	2,077 +197	+10%	+$6.96K	﹤0.01%	2517
2021 Q4	$82K	Buy	1,880 +743	+65%	+$35.2K	﹤0.01%	2315
2021 Q3	$58K	Buy	1,137 +260	+30%	+$13.6K	﹤0.01%	2478
2021 Q2	$46K	Buy	877 +352	+67%	+$16.5K	﹤0.01%	2562
2021 Q1	$24K	Hold	525	–	–	﹤0.01%	2888
2020 Q4	$24K	Hold	525	–	–	﹤0.01%	2167
2020 Q3	$21K	Buy	+525	New	+$20.2K	﹤0.01%	1949

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CAPTRUST Financial Advisors's IDNA Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2022, closing a stake of 1,402 shares — an estimated $41K sold.

CAPTRUST Financial Advisors first reported a position in IDNA in Q3 2020 and held it in 8 quarters. The position peaked at $82K in Q4 2021. 67 funds tracked by Wall St. Rank hold IDNA as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 1,402 iShares Genomics Immunology and Healthcare ETF shares in Q3 2022, an estimated $41K.
CAPTRUST Financial Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 8 quarters.
CAPTRUST Financial Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $82K in Q4 2021.
67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.